ADVANTAGE visceral pain consortium: Advanced Discovery of Visceral Analgesics via Neuroimmune Targets and the Genetics of Extreme Human Phenotype

Project Details

StatusActive
Effective start/end date1/07/2130/06/25

Funding

  • MRC: £19,211.00